-
Historic low death rates: 2026 data shows pensioner mortality back in line with pre-pandemic trends. The picture across different age groups is more complex.
-
Ongoing NHS pressure: A&E waits remain high. Cancer treatment delays persist.
-
Future longevity upside potential: Anti-obesity drugs (GLP-1s) and earlier cancer detection could materially improve survival and longevity.
-
Insurers stabilising assumptions: It appears that the insurance industry have now largely reflected the full impact of the pandemic within their assumptions.
-
Implication for trustees: Longevity expectations are shifting, so schemes should revisit assumptions as funding, surplus, and endgame outcomes are highly sensitive to them.
LCP's latest Longevity report explores whether emerging data signals the start of a new era, with record‑low death rates, rising life expectancy trends, and shifting industry assumptions.
Download the report to explore the findings in full and what they mean for pension schemes and sponsors.